J Duraj

570 total citations
51 papers, 494 citations indexed

About

J Duraj is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, J Duraj has authored 51 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 16 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in J Duraj's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (9 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). J Duraj is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (9 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). J Duraj collaborates with scholars based in Slovakia, Austria and Czechia. J Duraj's co-authors include J Sedlák, Ľuba Hunáková, Dana Cholujová, Ján Sedlák, Juraj Bodo, Jana Jakubı́ková, Paulina Gronesova, Olga Sedlakova, Ladislav Novotný and P Rauko and has published in prestigious journals such as British Journal of Cancer, Cancer Letters and Biochimie.

In The Last Decade

J Duraj

50 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Duraj Slovakia 14 301 125 56 56 55 51 494
Joseph T. Woitach United States 8 335 1.1× 91 0.7× 77 1.4× 50 0.9× 46 0.8× 11 534
Satoshi Sumida Japan 10 226 0.8× 141 1.1× 34 0.6× 28 0.5× 32 0.6× 16 418
Eun‐Sun Choi South Korea 18 344 1.1× 73 0.6× 38 0.7× 57 1.0× 70 1.3× 27 577
Roberta R. Ruela-de-Sousa Brazil 11 382 1.3× 99 0.8× 36 0.6× 30 0.5× 47 0.9× 12 556
Luigi Candussio Italy 15 231 0.8× 255 2.0× 52 0.9× 26 0.5× 122 2.2× 42 664
John T. Piper United States 14 484 1.6× 135 1.1× 36 0.6× 22 0.4× 23 0.4× 19 689
Sema Sentürker United States 12 646 2.1× 89 0.7× 43 0.8× 32 0.6× 37 0.7× 14 825
Shankar Jagadeesh United States 12 353 1.2× 56 0.4× 63 1.1× 60 1.1× 24 0.4× 18 537
Valentina Della Pietra Italy 11 433 1.4× 183 1.5× 78 1.4× 20 0.4× 112 2.0× 13 777
Seok-Il Hong South Korea 10 365 1.2× 116 0.9× 29 0.5× 17 0.3× 49 0.9× 15 531

Countries citing papers authored by J Duraj

Since Specialization
Citations

This map shows the geographic impact of J Duraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Duraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Duraj more than expected).

Fields of papers citing papers by J Duraj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Duraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Duraj. The network helps show where J Duraj may publish in the future.

Co-authorship network of co-authors of J Duraj

This figure shows the co-authorship network connecting the top 25 collaborators of J Duraj. A scholar is included among the top collaborators of J Duraj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Duraj. J Duraj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hunáková, Ľuba, Paulina Gronesova, Eva Horváthová, et al.. (2014). Modulation of cisplatin sensitivity in human ovarian carcinoma A2780 and SKOV3 cell lines by sulforaphane. Toxicology Letters. 230(3). 479–486. 30 indexed citations
2.
Duraj, J, Michal Pastorek, Dana Cholujová, et al.. (2013). Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line. Neoplasma. 60(6). 627–634. 6 indexed citations
3.
Cholujová, Dana, Jana Jakubı́ková, Ľuba Hunáková, et al.. (2012). MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer Immunology Immunotherapy. 62(3). 437–445. 49 indexed citations
4.
5.
Hunáková, Ľuba, Olga Sedlakova, Dana Cholujová, et al.. (2009). Modulation of markers associated with aggressive phenotype in MDA-MB-231 breast carcinoma cells by sulforaphane.. Neoplasma. 56(6). 548–556. 37 indexed citations
6.
Bodo, Juraj, Ľuba Hunáková, P. Kvasnička, et al.. (2006). Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations. British Journal of Cancer. 95(10). 1348–1353. 19 indexed citations
7.
Sedlakova, Olga, et al.. (1999). Angiogenesis inhibitor TNP-470: cytotoxic effects on human neoplastic cell lines.. PubMed. 46(5). 283–9. 15 indexed citations
8.
Hunáková, Ľuba, et al.. (1997). Human multidrug-resistant (MRP,p190) myeloid leukemia HL-60/ADR cells in vitro: resistance to the mevalonate pathway inhibitor lovastatin.. PubMed. 44(6). 366–9. 9 indexed citations
9.
10.
11.
Hunáková, Ľuba, et al.. (1994). Tyrosine kinase inhibitor-induced differentiation of K-562 cells: alterations of cell cycle and cell surface phenotype. Cancer Letters. 81(1). 81–87. 16 indexed citations
12.
13.
Morais, Marcos Antônio de, Jela Brozmanová, Mara Silveira Benfato, et al.. (1994). The E. coli recA gene can restore the defect in mutagenesis of the pso4-1 mutant of S. cerevisiae. Mutation Research/DNA Repair. 314(3). 209–220. 11 indexed citations
14.
Sedlák, J, et al.. (1993). Modulation of protectin (CD59 antigen) cell surface expression on human neoplastic cell lines.. PubMed. 40(6). 337–40. 3 indexed citations
15.
Brozmanová, Jela, et al.. (1991). The Escherichia coli recA gene increases resistance of the yeast Saccharomyces cerevisiae to ionizing and ultraviolet radiation. Molecular and General Genetics MGG. 227(3). 473–480. 17 indexed citations
16.
Sedlák, J, et al.. (1990). Biochemical and immunological phenotype alterations in human monoblastoid cell line U-937 induced by physiological (interferon-alpha, retinoic acid) and nonphysiological (phorbol ester) inducers.. PubMed. 37(3). 317–31. 3 indexed citations
17.
Duraj, J, et al.. (1987). Supplementary characteristics of anti-MHC class II monoclonal antibodies elicited by an ALL cell line: immunofluorescence cytofluorometry, C-dependent cytotoxicity, two-dimensional analysis of antigen.. PubMed. 34(4). 417–25. 1 indexed citations
18.
Duraj, J, et al.. (1986). Two-dimensional analysis of metabolically and cell surface radiolabeled proteins of some human lymphoid and myeloid leukemia cell lines. I. 35S-methionine labeled, lactoperoxidase radioiodinated and 3H-reductively methylated proteins.. PubMed. 33(5). 555–64. 1 indexed citations
19.
Poláková, K, et al.. (1985). Monoclonal antibodies against MHC class II antigens elicited with a human non-T, non-B acute lymphoblastic leukemia cell line.. PubMed. 32(6). 641–8. 4 indexed citations
20.
Duraj, J, et al.. (1983). Differentiation of human myeloid leukemia cell lines induced by tumor-promoting phorbol ester (TPA). II. Electrophoretic patterns of metabolically- and cell surface radiolabeled proteins and glycoproteins.. PubMed. 30(3). 273–80. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph T. Woitach Breakdown of academic impact, for papers by Satoshi Sumida Breakdown of academic impact, for papers by Eun‐Sun Choi Breakdown of academic impact, for papers by Roberta R. Ruela-de-Sousa Breakdown of academic impact, for papers by Luigi Candussio Breakdown of academic impact, for papers by John T. Piper Breakdown of academic impact, for papers by Sema Sentürker Breakdown of academic impact, for papers by Shankar Jagadeesh Breakdown of academic impact, for papers by Valentina Della Pietra Breakdown of academic impact, for papers by Seok-Il Hong
Rankless by CCL
2026